{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:01:30Z","timestamp":1773392490847,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.alit.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T08:29:45Z","timestamp":1706603385000},"page":"382-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A systematic review and meta-analysis of macrolides in the management of adult patients with asthma"],"prefix":"10.1016","volume":"73","author":[{"given":"Hiroshi","family":"Ohnishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihito","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johsuke","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Eitoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2024.01.002_bib1","author":"Global Initiative for Asthma"},{"key":"10.1016\/j.alit.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41533-021-00222-2","article-title":"Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-\/high-dose ICS\/LABA","volume":"31","author":"Inoue","year":"2021","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.alit.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pharmrev.121.000300","article-title":"Nonantimicrobial actions of macrolides: overview and perspectives for future development","volume":"73","author":"Kricker","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.alit.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jjco\/hyaa258","article-title":"Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis","volume":"51","author":"Awano","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.alit.2024.01.002_bib9","first-page":"CD002997","article-title":"Macrolides versus placebo for chronic asthma","volume":"11","author":"Undela","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ppul.25783","article-title":"The efficacy and safety of azithromycin in treatment for childhood asthma: a systematic review and meta-analysis","volume":"57","author":"Pan","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.alit.2024.01.002_bib11","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"10.1016\/j.alit.2024.01.002_bib12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.alit.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.alit.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0091-6749(93)90345-G","article-title":"Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma","volume":"91","author":"Kamada","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2500\/aap.2007.28.2958","article-title":"Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report","volume":"28","author":"Piacentini","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.alit.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jaci.2008.09.028","article-title":"Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study","volume":"122","author":"Strunk","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2500\/ar.2016.7.0168","article-title":"Effects of low-dose clarithromycin added to fluticasone on inflammatory markers and pulmonary function among children with asthma: a randomized clinical trial","volume":"7","author":"Wan","year":"2016","journal-title":"Allergy Rhinol (Providence)"},{"issue":"Suppl 51","key":"10.1016\/j.alit.2024.01.002_bib18","first-page":"358s","article-title":"Open-trial randomized comparative trial of the efficacy of the azithromycin in the 8 week treatment of mild to moderate asthma","volume":"30","author":"Belotserkovskaya","year":"2007","journal-title":"Eur Respir J"},{"issue":"Suppl 54","key":"10.1016\/j.alit.2024.01.002_bib19","first-page":"P1176","article-title":"Therapeutic effect of low dose roxithromycin in chronic stable mild-to-moderate asthma","volume":"36","author":"Kapoor","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2024.01.002_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2010.07.024","article-title":"A\u00a0trial of clarithromycin for the treatment of suboptimally controlled asthma","volume":"126","author":"Sutherland","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.01.002_bib22","first-page":"719","article-title":"[Clinical impacts of azithromycin on lung function and cytokines for asthmatic patients]","volume":"36","author":"He","year":"2009","journal-title":"[Fudan Univ J Med Sci]"},{"key":"10.1016\/j.alit.2024.01.002_bib23","first-page":"1948","article-title":"[Effect of clarithromycin on non-eosinophilic refractory asthma]","volume":"17","author":"Wang","year":"2012","journal-title":"[J Clin Pulm Med]"},{"key":"10.1016\/j.alit.2024.01.002_bib24","first-page":"122","article-title":"[Clinical impacts of low-dose azithromycin on lung function and fraction of exhaled nitric oxide concentration in bronchial asthma]","volume":"11","author":"Wang","year":"2014","journal-title":"[Med Innov China]"},{"key":"10.1016\/j.alit.2024.01.002_bib25","first-page":"119","article-title":"[The study on effect of roxithromycin combined with budesonide in\u00a0therapy in patients with asthma]","volume":"11","author":"Xiao","year":"2013","journal-title":"[Guide Chin Med]"},{"key":"10.1016\/j.alit.2024.01.002_bib26","first-page":"184","article-title":"[Clinical study on efficacy of roxithromycin combined with inhaled budesonide dry powder inhalation on asthma]","volume":"13","author":"Yan","year":"2008","journal-title":"[Chin J Pharmacol Ther]"},{"key":"10.1016\/j.alit.2024.01.002_bib27","first-page":"159","article-title":"[Clinical effect of azithromycin combined with Seretide for asthma]","volume":"25","author":"Zhang","year":"2013","journal-title":"[Strait Pharm J]"},{"key":"10.1016\/j.alit.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1183\/09031936.00093913","article-title":"Randomised controlled trial of azithromycin in smokers with asthma","volume":"42","author":"Cameron","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1371\/journal.pctr.0010011","article-title":"Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma","volume":"1","author":"Hahn","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"10.1016\/j.alit.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3122\/jabfm.2012.04.110309","article-title":"Azithromycin for bronchial asthma in adults: an effectiveness trial","volume":"25","author":"Hahn","year":"2012","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.alit.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"106494","DOI":"10.1016\/j.rmed.2021.106494","article-title":"Effect of azithromycin on bronchial wall thickness in severe persistent asthma: a double-blind placebo-controlled randomized clinical trial","volume":"185","author":"Sadeghdoust","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2024.01.002_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.164.4.2011040","article-title":"Trial of\u00a0roxithromycin in subjects with asthma and serological evidence of infection\u00a0with Chlamydia pneumoniae","volume":"164","author":"Black","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2024.01.002_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2222.1999.00551.x","article-title":"Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma","volume":"29","author":"Shoji","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2024.01.002_bib34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1081-1206(10)62409-X","article-title":"Clarithromycin suppress bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma","volume":"84","author":"Amayasu","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2024.01.002_bib35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.04.00118404","article-title":"Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma","volume":"23","author":"Kostadima","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","article-title":"Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin","volume":"121","author":"Kraft","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.alit.2024.01.002_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm\/147.2.398","article-title":"A\u00a0double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids","volume":"147","author":"Nelson","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.alit.2024.01.002_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2024.01.002_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.01.002_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific Quality of Life Questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.alit.2024.01.002_bib41","doi-asserted-by":"crossref","first-page":"2002436","DOI":"10.1183\/13993003.02436-2020","article-title":"The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma","volume":"57","author":"O'Neill","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2024.01.002_bib42","doi-asserted-by":"crossref","first-page":"2000194","DOI":"10.1183\/13993003.00194-2020","article-title":"AMAZES Study Research Group. Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma","volume":"56","author":"Taylor","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2024.01.002_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thoraxjnl-2020-216331","article-title":"Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy","volume":"76","author":"Shukla","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2024.01.002_bib44","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/all.14768","article-title":"Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment","volume":"76","author":"Niessen","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.01.002_bib45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.36469\/jheor.2021.28327","article-title":"Estimating the economic and clinical value of reducing antimicrobial resistance to three Gram-negative pathogens in Japan","volume":"8","author":"Matsumoto","year":"2021","journal-title":"J\u00a0Health Econ Outcomes Res"},{"key":"10.1016\/j.alit.2024.01.002_bib46","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.chest.2022.02.025","article-title":"Azithromycin for poorly controlled asthma in children: a randomized controlled trial","volume":"161","author":"Ghimire","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.alit.2024.01.002_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893024000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893024000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T13:26:25Z","timestamp":1720790785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893024000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1323893024000030"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2024.01.002","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of macrolides in the management of adult patients with asthma","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}